Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Over 4 decades, French children teach about LCH.

Blood·2025
Same author

Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.

Nature communications·2024
Same author

Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.

Nature communications·2024
Same author

Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures.

Cancer·2024
Same author

MatchMiner: an open-source platform for cancer precision medicine.

NPJ precision oncology·2022
Same author

Demonstration of high-speed and low-complexity continuous variable quantum key distribution system with local local oscillator.

Scientific reports·2021

Video Experimental Relacionado

Updated: May 13, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

La ciclina C/cdk3 promueve la salida G0 dependiente de Rb.

Shengjun Ren1, Barrett J Rollins

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Cell
|April 16, 2004
PubMed
Resumen

La salida celular G0 implica la ciclina C y cdk3, que fosforilan pRb para permitir la reentrada del ciclo celular. Esta combinación distinta de ciclina / cdk regula la transición G0 / G1, similar a la regulación de la fase G1 / S.

Más Videos Relacionados

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Videos de Experimentos Relacionados

Last Updated: May 13, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Área de la Ciencia:

  • Biología celular Biología celular.
  • Biología Molecular Biología Molecular
  • La bioquímica es la bioquímica.

Sus antecedentes:

  • El ciclo celular implica fases distintas, incluyendo G0 (estado de reposo) y G1 (preparación para la síntesis de ADN).
  • Si bien la transición G1/S es bien entendida, la regulación de la transición G0/G1 sigue siendo en gran medida desconocida.
  • La inactivación de la proteína del retinoblastoma (pRb) es crucial para la reentrada del ciclo celular desde G0.0.

Objetivo del estudio:

  • Investigar los mecanismos moleculares que regulan la transición G0/G1.
  • Para identificar las proteínas clave involucradas en la fosforilación de pRb durante la salida de G0.
  • Para aclarar el papel de la ciclina C y sus kinasas asociadas en la regulación G0 / G1.

Principales métodos:

  • Análisis de los niveles de ARNm ciclina C durante la salida de G0.
  • Investigando la interacción de la ciclina C con las cinasas dependientes de la ciclina (cdks).
  • Evaluación del efecto del complejo ciclina C/cdk3 en la fosforilación de pRb en sitios específicos (S807/811).

Principales resultados:

  • Los niveles de ciclina C alcanzan su punto máximo durante la salida de G0, lo que sugiere un papel en este proceso.
  • Un grupo de ciclina C no asociado a cdk8 forma un complejo con cdk3.
  • Este complejo de ciclina C/cdk3 fosforila pRb en S807/811, que es esencial para una salida G0 eficiente.

Conclusiones:

  • La transición G0/G1 está regulada por una combinación distinta de ciclina/cdk, específicamente la ciclina C/cdk3.
  • La fosforilación de pRb en S807/811 por ciclina C/cdk3 es un paso crítico para que las células salgan de G0.0.
  • Este hallazgo revela un mecanismo de regulación análogo a la transición G1/S pero con un par diferente de ciclina/cdk.